Clinical Trial Update: PK Effects of Bifeprunox & Valproate in Bipolar I [Phase 2]

View source ↗

Summary

Phase 2 trial update examining pharmacokinetic interactions between bifeprunox and valproate in Bipolar I Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Bifeprunox (bifeprunox)
• Valproate (valproate)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Bipolar I Disorder | Phase 2 | Status: COMPLETED